{
  "docId": "019de072-fb61-72df-84cb-88e5545aef17",
  "docSlug": "ab8c2c2aa3a78f1c4e59d8338668e5e1",
  "documentTitle": "Genetron | Results Presentation Deck | 29 slides",
  "authorId": "genetron",
  "authorName": "Genetron",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 29,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "balanced",
  "nDataPoints": 5,
  "notes": "The slide segments the market into Diagnosis & Monitoring (LDT+IVD and Biopharma Services) and Early Screening, providing specific market size estimates for each.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-fb61-72df-84cb-88e5545aef17/3",
  "deckHref": "/decks/019de072-fb61-72df-84cb-88e5545aef17",
  "deckJsonHref": "/decks/019de072-fb61-72df-84cb-88e5545aef17.json",
  "deckAnchorHref": "/decks/019de072-fb61-72df-84cb-88e5545aef17#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.72,
        "x": 0.14,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "Our Proprietary Technology: One-step Seq, Mutation Capsules",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72cc76e8-2089-4743-a3ed-d4ceac7d04aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "1. Frost & Sullivan, Market potential in China as of 2023\n2. Euromonitor, Globalcan, Company internal estimates market potential",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12b6f13d-cbb9-49d8-98da-f78d618bc7bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.9,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "table",
      "text": "TAM: Diagnosis & Monitoring (LDT+IVD: $6.7B, $14B; Biopharma Services: $0.5B) and TAM: Early Screening (Liver: $7.2B, CRC: $23.0B, Lung: $5.8B)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd3f9ca3-8f23-4b4a-853b-25a6d3a6c104",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.04
      },
      "kind": "title",
      "text": "Leading Precision Oncology Company in China",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "95ebb0a2-5715-4ce5-9eba-61f9ef645bc3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 3,
      "beatId": "82b78546-c96e-46d2-9768-45996394088b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The document presents market sizing and key takeaways, indicating a clear problem statement.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}